Myeloma Crowd Radio: Dr. Daniel Fowler, MD, NIH

Immunotherapies are making their way into the clinic and as they do, more exciting options will be available for patients. Researchers are now studying the best possible way to leverage the standard and effective multiple myeloma treatments with ways to empower the immune system to fight myeloma. Learn what Dr. Daniel Fowler, MD of the NIH is doing to use a Th1 and Th2 immune therapy treatment in combination with stem cell transplant in an early clinical trial. 

Special thanks to our Myeloma Crowd Radio episode sponsor, Amgen.